Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,93%
1 115,70
+20,86
+1,93%
—1 094,841 107,911 117,141 107,91——
SIXC
Communications
SIXC
Communications
SIXC
+1,46%
613,04
+8,83
+1,46%
—604,21604,21614,49604,21——
SIXE
Energy
SIXE
Energy
SIXE
-3,80%
1 202,26
-47,45
-3,80%
—1 249,711 219,461 219,461 191,66——
SIXI
Industrials
SIXI
Industrials
SIXI
+2,23%
1 778,01
+38,75
+2,23%
—1 739,261 754,111 778,251 754,11——
SIXM
Financials
SIXM
Financials
SIXM
+0,93%
641,51
+5,88
+0,93%
—635,63637,46643,42637,46——
SIXR
Staples
SIXR
Staples
SIXR
-0,01%
848,24
-0,080
-0,01%
—848,32850,90853,05848,13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1,36%
219,71
+2,95
+1,36%
—216,76216,76220,02216,76——
SIXT
Technology
SIXT
Technology
SIXT
+1,69%
3 391,36
+56,22
+1,69%
—3 335,143 376,133 392,263 360,29——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,55%
924,80
-14,54
-1,55%
—939,34937,32937,59924,75——
SIXV
Health care
SIXV
Health care
SIXV
+0,29%
1 472,44
+4,27
+0,29%
—1 468,171 468,981 476,501 465,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1,37%
2 419,89
+32,80
+1,37%
—2 387,092 394,182 421,572 394,18——
ALNOV:EPA
Novacyt SA
0,35 €
+3,55%
(+0,012) 1D
6-май, 16:49:59 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALNOV...
Open
0,34 €
High
0,36 €
Low
0,32 €
Mkt. cap
25,95 млн
Avg. vol.
144,96 миң
Volume
341,36 миң
52-wk high
0,74 €
52-wk low
0,29 €
EPS
-0,50 €
Shares outstanding
72,59 млн
No. of employees
234
News stories
From sources across the web
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees234
Founded2006-ж., 3-июл.
Headquarters-
Sector-
Websitenovacyt.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
2024-ж. сен.
2024-ж. дек.
2025-ж. мар.
2025-ж. июн.
Revenue
-
-
4,90 млн
4,90 млн
Cost of goods sold
-
-
1,64 млн
1,64 млн
Cost of revenue
-
-
1,64 млн
1,64 млн
Research and development expenses
-
-
1,02 млн
1,02 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
5,51 млн
5,51 млн
Operating expense
-
-
6,43 млн
6,43 млн
Total operating expenses
-
-
8,08 млн
8,08 млн
Operating income
-
-
-3,18 млн
-3,18 млн
Other non operating income
-
-
-31,00 миң
-31,00 миң
EBT including unusual items
-
-
-3,51 млн
-3,51 млн
EBT excluding unusual items
-
-
-3,12 млн
-3,12 млн
Income tax expense
-
-
-133,50 миң
-133,50 миң
Effective tax rate
-
-
3,80%
3,80%
Other operating expenses
-
-
-97,50 миң
-97,50 миң
Net income
-
-
-3,17 млн
-3,17 млн
Net profit margin
-
-
-64,76%
-64,76%
Earnings per share
-
-
-
-
Interest and investment income
-
-
177,00 миң
177,00 миң
Interest expense
-
-
-154,00 миң
-154,00 миң
Net interest expenses
-
-
23,00 миң
23,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-2,17 млн
-2,17 млн
Gain or loss from assets sale
-
-
-147,50 миң
-147,50 миң
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer